APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Avelumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Avelumab Market Analysis and Forecast 2026-2032

Report ID 173968460223 December 2025196 pages

Choose your research edition.

Industry ResearchAvelumab Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Avelumab Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Avelumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avelumab Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Avelumab Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Avelumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Avelumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Avelumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Avelumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Avelumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Avelumab include Merck and Pfizer etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Avelumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Avelumab, also provides the sales of main regions and countries. Of the upcoming market potential for Avelumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Avelumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Avelumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Avelumab sales, projected growth trends, production technology, application and end-user industry.

Avelumab Segment by Company

Merck

Pfizer

Avelumab Segment by Type

By Usage

By Specifications

Avelumab Segment by Application

Merkel-cell Carcinoma

Non-small Cell Lung Carcinoma (NSCLC)

Others

Avelumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avelumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avelumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avelumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Avelumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Avelumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avelumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Avelumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Type I Major Manufacturers Table 3. Type II Major Manufacturers Table 4. Global Avelumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Merkel-cell Carcinoma Major Manufacturers Table 6. Non-small Cell Lung Carcinoma (NSCLC) Major Manufacturers Table 7. Others Major Manufacturers Table 8. Avelumab Industry Trends Table 9. Avelumab Industry Drivers Table 10. Avelumab Industry Opportunities and Challenges Table 11. Avelumab Industry Restraints Table 12. Global Avelumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Avelumab Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Avelumab Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Avelumab Revenue Market Share by Region (2021-2026) Table 16. Global Avelumab Revenue Market Share by Region (2027-2032) Table 17. Global Avelumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Avelumab Sales by Region (2021-2026) & (k units) Table 19. Global Avelumab Sales by Region (2027-2032) & (k units) Table 20. Global Avelumab Sales Market Share by Region (2021-2026) Table 21. Global Avelumab Sales Market Share by Region (2027-2032) Table 22. Global Avelumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Avelumab Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Avelumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Avelumab Sales Market Share by Manufacturers (2021-2026) Table 26. Global Avelumab Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Avelumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Avelumab Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Avelumab Manufacturers, Product Type & Application Table 30. Global Avelumab Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Avelumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Avelumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Avelumab Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Avelumab Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Avelumab Revenue Market Share by Type (2021-2026) Table 37. Global Avelumab Revenue Market Share by Type (2027-2032) Table 38. Global Avelumab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Avelumab Sales by Type (2021-2026) & (k units) Table 40. Global Avelumab Sales by Type (2027-2032) & (k units) Table 41. Global Avelumab Sales Market Share by Type (2021-2026) Table 42. Global Avelumab Sales Market Share by Type (2027-2032) Table 43. Global Avelumab Price by Type (2021-2026) & (US$/unit) Table 44. Global Avelumab Price by Type (2027-2032) & (US$/unit) Table 45. Global Avelumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Avelumab Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Avelumab Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Avelumab Revenue Market Share by Application (2021-2026) Table 49. Global Avelumab Revenue Market Share by Application (2027-2032) Table 50. Global Avelumab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Avelumab Sales by Application (2021-2026) & (k units) Table 52. Global Avelumab Sales by Application (2027-2032) & (k units) Table 53. Global Avelumab Sales Market Share by Application (2021-2026) Table 54. Global Avelumab Sales Market Share by Application (2027-2032) Table 55. Global Avelumab Price by Application (2021-2026) & (US$/unit) Table 56. Global Avelumab Price by Application (2027-2032) & (US$/unit) Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Avelumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Merck Avelumab Product Portfolio Table 61. Merck Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Avelumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Pfizer Avelumab Product Portfolio Table 66. Pfizer Recent Development Table 67. North America Avelumab Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Avelumab Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Avelumab Sales by Type (2021-2026) & (k units) Table 70. North America Avelumab Sales by Type (2027-2032) & (k units) Table 71. North America Avelumab Sales Price by Type (2021-2026) & (US$/unit) Table 72. North America Avelumab Sales Price by Type (2027-2032) & (US$/unit) Table 73. North America Avelumab Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Avelumab Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Avelumab Sales by Application (2021-2026) & (k units) Table 76. North America Avelumab Sales by Application (2027-2032) & (k units) Table 77. North America Avelumab Sales Price by Application (2021-2026) & (US$/unit) Table 78. North America Avelumab Sales Price by Application (2027-2032) & (US$/unit) Table 79. North America Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Avelumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Avelumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Avelumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 83. North America Avelumab Sales by Country (2021-2026) & (k units) Table 84. North America Avelumab Sales by Country (2027-2032) & (k units) Table 85. North America Avelumab Sales Price by Country (2021-2026) & (US$/unit) Table 86. North America Avelumab Sales Price by Country (2027-2032) & (US$/unit) Table 87. United States Avelumab Revenue (2021-2032) & (US$ Million) Table 88. Canada Avelumab Revenue (2021-2032) & (US$ Million) Table 89. Mexico Avelumab Revenue (2021-2032) & (US$ Million) Table 90. Europe Avelumab Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Avelumab Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Avelumab Sales by Type (2021-2026) & (k units) Table 93. Europe Avelumab Sales by Type (2027-2032) & (k units) Table 94. Europe Avelumab Sales Price by Type (2021-2026) & (US$/unit) Table 95. Europe Avelumab Sales Price by Type (2027-2032) & (US$/unit) Table 96. Europe Avelumab Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Avelumab Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Avelumab Sales by Application (2021-2026) & (k units) Table 99. Europe Avelumab Sales by Application (2027-2032) & (k units) Table 100. Europe Avelumab Sales Price by Application (2021-2026) & (US$/unit) Table 101. Europe Avelumab Sales Price by Application (2027-2032) & (US$/unit) Table 102. Europe Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Avelumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Avelumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Avelumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. Europe Avelumab Sales by Country (2021-2026) & (k units) Table 107. Europe Avelumab Sales by Country (2027-2032) & (k units) Table 108. Europe Avelumab Sales Price by Country (2021-2026) & (US$/unit) Table 109. Europe Avelumab Sales Price by Country (2027-2032) & (US$/unit) Table 110. Germany Avelumab Revenue (2021-2032) & (US$ Million) Table 111. France Avelumab Revenue (2021-2032) & (US$ Million) Table 112. U.K. Avelumab Revenue (2021-2032) & (US$ Million) Table 113. Italy Avelumab Revenue (2021-2032) & (US$ Million) Table 114. Russia Avelumab Revenue (2021-2032) & (US$ Million) Table 115. Spain Avelumab Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Avelumab Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Avelumab Revenue (2021-2032) & (US$ Million) Table 118. Sweden Avelumab Revenue (2021-2032) & (US$ Million) Table 119. Poland Avelumab Revenue (2021-2032) & (US$ Million) Table 120. China Avelumab Revenue by Type (2021-2026) & (US$ Million) Table 121. China Avelumab Revenue by Type (2027-2032) & (US$ Million) Table 122. China Avelumab Sales by Type (2021-2026) & (k units) Table 123. China Avelumab Sales by Type (2027-2032) & (k units) Table 124. China Avelumab Sales Price by Type (2021-2026) & (US$/unit) Table 125. China Avelumab Sales Price by Type (2027-2032) & (US$/unit) Table 126. China Avelumab Revenue by Application (2021-2026) & (US$ Million) Table 127. China Avelumab Revenue by Application (2027-2032) & (US$ Million) Table 128. China Avelumab Sales by Application (2021-2026) & (k units) Table 129. China Avelumab Sales by Application (2027-2032) & (k units) Table 130. China Avelumab Sales Price by Application (2021-2026) & (US$/unit) Table 131. China Avelumab Sales Price by Application (2027-2032) & (US$/unit) Table 132. Asia Avelumab Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Avelumab Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Avelumab Sales by Type (2021-2026) & (k units) Table 135. Asia Avelumab Sales by Type (2027-2032) & (k units) Table 136. Asia Avelumab Sales Price by Type (2021-2026) & (US$/unit) Table 137. Asia Avelumab Sales Price by Type (2027-2032) & (US$/unit) Table 138. Asia Avelumab Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Avelumab Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Avelumab Sales by Application (2021-2026) & (k units) Table 141. Asia Avelumab Sales by Application (2027-2032) & (k units) Table 142. Asia Avelumab Sales Price by Application (2021-2026) & (US$/unit) Table 143. Asia Avelumab Sales Price by Application (2027-2032) & (US$/unit) Table 144. Asia Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Avelumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Avelumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Avelumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. Asia Avelumab Sales by Country (2021-2026) & (k units) Table 149. Asia Avelumab Sales by Country (2027-2032) & (k units) Table 150. Asia Avelumab Sales Price by Country (2021-2026) & (US$/unit) Table 151. Asia Avelumab Sales Price by Country (2027-2032) & (US$/unit) Table 152. Japan Avelumab Revenue (2021-2032) & (US$ Million) Table 153. South Korea Avelumab Revenue (2021-2032) & (US$ Million) Table 154. India Avelumab Revenue (2021-2032) & (US$ Million) Table 155. Australia Avelumab Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Avelumab Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Avelumab Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Avelumab Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Avelumab Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Avelumab Sales by Type (2021-2026) & (k units) Table 161. SAMEA Avelumab Sales by Type (2027-2032) & (k units) Table 162. SAMEA Avelumab Sales Price by Type (2021-2026) & (US$/unit) Table 163. SAMEA Avelumab Sales Price by Type (2027-2032) & (US$/unit) Table 164. SAMEA Avelumab Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Avelumab Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Avelumab Sales by Application (2021-2026) & (k units) Table 167. SAMEA Avelumab Sales by Application (2027-2032) & (k units) Table 168. SAMEA Avelumab Sales Price by Application (2021-2026) & (US$/unit) Table 169. SAMEA Avelumab Sales Price by Application (2027-2032) & (US$/unit) Table 170. SAMEA Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Avelumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Avelumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Avelumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. SAMEA Avelumab Sales by Country (2021-2026) & (k units) Table 175. SAMEA Avelumab Sales by Country (2027-2032) & (k units) Table 176. SAMEA Avelumab Sales Price by Country (2021-2026) & (US$/unit) Table 177. SAMEA Avelumab Sales Price by Country (2027-2032) & (US$/unit) Table 178. Brazil Avelumab Revenue (2021-2032) & (US$ Million) Table 179. Argentina Avelumab Revenue (2021-2032) & (US$ Million) Table 180. Chile Avelumab Revenue (2021-2032) & (US$ Million) Table 181. Colombia Avelumab Revenue (2021-2032) & (US$ Million) Table 182. Peru Avelumab Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Avelumab Revenue (2021-2032) & (US$ Million) Table 184. Israel Avelumab Revenue (2021-2032) & (US$ Million) Table 185. UAE Avelumab Revenue (2021-2032) & (US$ Million) Table 186. Turkey Avelumab Revenue (2021-2032) & (US$ Million) Table 187. Iran Avelumab Revenue (2021-2032) & (US$ Million) Table 188. Egypt Avelumab Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Avelumab Distributors List Table 192. Avelumab Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Avelumab Image Figure 2. Global Avelumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avelumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. Type I Image Figure 5. Type II Image Figure 6. Global Avelumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Avelumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Merkel-cell Carcinoma Image Figure 9. Non-small Cell Lung Carcinoma (NSCLC) Image Figure 10. Others Image Figure 11. Global Avelumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Avelumab Revenue (2021-2032) & (US$ Million) Figure 13. Global Avelumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Avelumab Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Avelumab Revenue Market Share by Region (2021-2032) Figure 16. Global Avelumab Sales (2021-2032) & (k units) Figure 17. Global Avelumab Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Avelumab Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Avelumab Sales YoY (2021-2032) & (k units) Figure 20. Europe Avelumab Sales YoY (2021-2032) & (k units) Figure 21. China Avelumab Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Avelumab Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Avelumab Sales YoY (2021-2032) & (k units) Figure 24. Global Avelumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Avelumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Avelumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Avelumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Avelumab Revenue Market Share by Type (2021-2032) Figure 30. Global Avelumab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Avelumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Avelumab Sales Market Share by Type (2021-2032) Figure 33. Global Avelumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Avelumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Avelumab Revenue Market Share by Application (2021-2032) Figure 36. Global Avelumab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Avelumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Avelumab Sales Market Share by Application (2021-2032) Figure 39. North America Avelumab Revenue Share by Type (2021-2032) Figure 40. North America Avelumab Sales Share by Type (2021-2032) Figure 41. North America Avelumab Revenue Share by Application (2021-2032) Figure 42. North America Avelumab Sales Share by Application (2021-2032) Figure 43. North America Avelumab Revenue Share by Country (2021-2032) Figure 44. North America Avelumab Sales Share by Country (2021-2032) Figure 45. Europe Avelumab Revenue Share by Type (2021-2032) Figure 46. Europe Avelumab Sales Share by Type (2021-2032) Figure 47. Europe Avelumab Revenue Share by Application (2021-2032) Figure 48. Europe Avelumab Sales Share by Application (2021-2032) Figure 49. Europe Avelumab Revenue Share by Country (2021-2032) Figure 50. Europe Avelumab Sales Share by Country (2021-2032) Figure 51. China Avelumab Revenue Share by Type (2021-2032) Figure 52. China Avelumab Sales Share by Type (2021-2032) Figure 53. China Avelumab Revenue Share by Application (2021-2032) Figure 54. China Avelumab Sales Share by Application (2021-2032) Figure 55. Asia Avelumab Revenue Share by Type (2021-2032) Figure 56. Asia Avelumab Sales Share by Type (2021-2032) Figure 57. Asia Avelumab Revenue Share by Application (2021-2032) Figure 58. Asia Avelumab Sales Share by Application (2021-2032) Figure 59. Asia Avelumab Revenue Share by Country (2021-2032) Figure 60. Asia Avelumab Sales Share by Country (2021-2032) Figure 61. SAMEA Avelumab Revenue Share by Type (2021-2032) Figure 62. SAMEA Avelumab Sales Share by Type (2021-2032) Figure 63. SAMEA Avelumab Revenue Share by Application (2021-2032) Figure 64. SAMEA Avelumab Sales Share by Application (2021-2032) Figure 65. SAMEA Avelumab Revenue Share by Country (2021-2032) Figure 66. SAMEA Avelumab Sales Share by Country (2021-2032) Figure 67. Avelumab Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Avelumab Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Applications
  • Merkel-cell Carcinoma
  • Non-small Cell Lung Carcinoma (NSCLC)
  • Others
Companies covered
  • Merck
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Avelumab Market by Type
  3. 1.2.1 Global Avelumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 By Usage
  5. 1.2.3 By Specifications
  6. 1.3 Avelumab Market by Application
  7. 1.3.1 Global Avelumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Merkel-cell Carcinoma
  9. 1.3.3 Non-small Cell Lung Carcinoma (NSCLC)
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Avelumab Market Dynamics
  1. 2.1 Avelumab Industry Trends
  2. 2.2 Avelumab Industry Drivers
  3. 2.3 Avelumab Industry Opportunities and Challenges
  4. 2.4 Avelumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Avelumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Avelumab Revenue by Region
  3. 3.2.1 Global Avelumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Avelumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Avelumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Avelumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Avelumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Avelumab Sales by Region
  9. 3.4.1 Global Avelumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Avelumab Sales by Region (2021-2026)
  11. 3.4.3 Global Avelumab Sales by Region (2027-2032)
  12. 3.4.4 Global Avelumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Avelumab Revenue by Manufacturers
  2. 4.1.1 Global Avelumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Avelumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Avelumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Avelumab Sales by Manufacturers
  6. 4.2.1 Global Avelumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Avelumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Avelumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Avelumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Avelumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Avelumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Avelumab Manufacturers, Product Type & Application
  13. 4.7 Global Avelumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Avelumab Market CR5 and HHI
  16. 4.8.2 2025 Avelumab Tier 1, Tier 2, and Tier 3
5 Avelumab Market by Type
  1. 5.1 Global Avelumab Revenue by Type
  2. 5.1.1 Global Avelumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Avelumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Avelumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Avelumab Sales by Type
  6. 5.2.1 Global Avelumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avelumab Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Avelumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Avelumab Price by Type
6 Avelumab Market by Application
  1. 6.1 Global Avelumab Revenue by Application
  2. 6.1.1 Global Avelumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Avelumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Avelumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Avelumab Sales by Application
  6. 6.2.1 Global Avelumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Avelumab Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Avelumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Avelumab Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Avelumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Avelumab Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Avelumab Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Avelumab Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
8 North America
  1. 8.1 North America Avelumab Market Size by Type
  2. 8.1.1 North America Avelumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Avelumab Sales by Type (2021-2032)
  4. 8.1.3 North America Avelumab Price by Type (2021-2032)
  5. 8.2 North America Avelumab Market Size by Application
  6. 8.2.1 North America Avelumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Avelumab Sales by Application (2021-2032)
  8. 8.2.3 North America Avelumab Price by Application (2021-2032)
  9. 8.3 North America Avelumab Market Size by Country
  10. 8.3.1 North America Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Avelumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Avelumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Avelumab Market Size by Type
  2. 9.1.1 Europe Avelumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Avelumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Avelumab Price by Type (2021-2032)
  5. 9.2 Europe Avelumab Market Size by Application
  6. 9.2.1 Europe Avelumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Avelumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Avelumab Price by Application (2021-2032)
  9. 9.3 Europe Avelumab Market Size by Country
  10. 9.3.1 Europe Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Avelumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Avelumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Avelumab Market Size by Type
  2. 10.1.1 China Avelumab Revenue by Type (2021-2032)
  3. 10.1.2 China Avelumab Sales by Type (2021-2032)
  4. 10.1.3 China Avelumab Price by Type (2021-2032)
  5. 10.2 China Avelumab Market Size by Application
  6. 10.2.1 China Avelumab Revenue by Application (2021-2032)
  7. 10.2.2 China Avelumab Sales by Application (2021-2032)
  8. 10.2.3 China Avelumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Avelumab Market Size by Type
  2. 11.1.1 Asia Avelumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Avelumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Avelumab Price by Type (2021-2032)
  5. 11.2 Asia Avelumab Market Size by Application
  6. 11.2.1 Asia Avelumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Avelumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Avelumab Price by Application (2021-2032)
  9. 11.3 Asia Avelumab Market Size by Country
  10. 11.3.1 Asia Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Avelumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Avelumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Avelumab Market Size by Type
  2. 12.1.1 SAMEA Avelumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Avelumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Avelumab Price by Type (2021-2032)
  5. 12.2 SAMEA Avelumab Market Size by Application
  6. 12.2.1 SAMEA Avelumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Avelumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Avelumab Price by Application (2021-2032)
  9. 12.3 SAMEA Avelumab Market Size by Country
  10. 12.3.1 SAMEA Avelumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Avelumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Avelumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Avelumab Value Chain Analysis
  2. 13.1.1 Avelumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Avelumab Production Mode & Process
  6. 13.2 Avelumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Avelumab Distributors
  9. 13.2.3 Avelumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst